Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Rocket Pharmaceuticals Announces Clearance of IND for RP-A501 Gene Therapy for Danon Disease

firstwordpharmaJanuary 23, 2019

Tag: gene therapy , Danon Disease , clearance , Rocket Pharmaceuticals , gene therapy

PharmaSources Customer Service